| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Obesity > FBCx, Obesity, Fiber and Weight Management |
|
E-Articles - FBCx, Obesity, Fiber and Weight Management
Obesity, a body mass index (BMI) greater than 30.0 kg/m squared
has become a worldwide epidemic. Nearly one-third of the population in the
US is obese and another one-third of the adult population is overweight (BMI 25.0 - 29.9 kg/m squared). The incidence of severe obesit According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product y (BMI greater than
40 kg/m squared) more than doubled during the decade of the 90’s. The
consequences to one’s health for being overweight include increased risk of
developing: Heart disease High blood pressure Type 2 diabetes Elevated blood lipids Certain ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ancers Muscle and skeletal disorders Sleep apnea Complications in pregnancy Depression and other psychological problems The total direct (healthcare) and indirect (lost productivity) costs were estimated to be a staggering $117 billon in 2000, or about one-half lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. of the total costs
caused by hurricane Katrina, the worst natural disaster in the history of
the USA. The real difference between the costs for Katrina and for obesity
might best be described as the difference between a one-time and an ever increasing
recurring expense. In the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe bsence of effective treatment, the costs of obesity
cannot help but do severe damage to the economy. Fiber is defined as a dietary constituent that is not degraded into absorbable units within the stomach or small intestine. Soluble fibers are more soluble in water relati d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ve to insoluble fibers. To further classify dietary fiber
it is said that they are either fermentable or nonfermentable, depending on whether or not undigested fibers are consumed
by the microbes contained in the large bowel; this fermentation is the source
of the gas and hence m ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ch locker-room humor that accompanies a high fiber
diet. The idea of increasing dietary fiber for weight management and promotion of good health is not a new one. A recent study has indicated that a daily increase of 10 grams of dietary fiber intake lowers the risk of coronary easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi vents by 12% and coronary deaths by 19%. Interestingly,
this study also found that obese individuals have significantly higher fat
and lower fiber consumption compared to normal weight individuals; furthermore
that there is no difference in energy intake between the obese and nor nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically al
weight individuals. We might conclude from this that the difference in body
weight, between normal and obese individuals, has more to do with fat than
energy consumption. Some researchers have concluded that by increasing daily
fiber intake by 14 grams reduces energy intake and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ by 10% and causes a decrease
in body weight. The weight reducing effect of dietary fiber was found to
be more pronounced in obese than in normal weight individuals. There are numerous products available from nutritional food supplement stores, pharmacies and supermarkets, not t ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi mention a plethora of websites that contain either specific fibers
or combinations of fibers. Almost all of these products guarantee your satisfaction,
but not necessarily your weight loss. All of these products base their (inferred)
weight loss claims upon one of two concepts; ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a fiber as a fat absorber or fiber
as a bulking agent that increases your feeling of fullness. Until the introduction
of FBCx none of these claims have been substantiated in the scientific literature. Weight management is really not rocket science; it is simply a matter of dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod alancing energy intake with energy required. Unfortunately, as your mother
may have told you, the devil is in the details. The culture that we have
embraced in the West and which we are rapidly exporting around the world,
demands plenty of inexpensive, good tasting, high energy cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin food and as little
physical labor/activity as is possible. The result is that we tend to eat
more calories than we need
causing our bodies to store the unused calories as fat. In order to lose
excess weight and then maintain a desired weight requires a lifestyle change
that is tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen so great that most of us will not even consider it, and those of us that do usually last only about 60-90
days on our Spartan regime. If you can do it, go for it and relish the fact
that you are in a very elite club of very disciplined individuals. It is with these obstacles to
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel eight management in mind that we developed FBCx. FBCx is a soluble, all natural, clinically tested, dietary fiber that is considered to be safe for human consumption at any level by the WHO (World health Organization) and has GRAS (Generally Recognized As Safe) status in t ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e USA. FBCx is unlike any other fiber that we know of in
that it has the very unique ability to form a stable complex with and reduce
the bioavailability of nine times its own weight in dietary fat. Taking six
one-gram tablets of FBCx as directed with fat containing meals effect y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ively
eliminates about 54 grams of fat or the equivalent of 500 kcal from a normal
North American diet with no known side effects. Thus if your diet and weight
is more or less constant prior to starting FBCx, you should be able to lose 3,500 kcal (7?500 per day)
or 1-1? pounds o . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de body weight per week. This 1-1? pounds per week may not
sound like much but it is what is considered to be a safe rate and when you
multiply it by 52 weeks in a year, it quickly becomes significant. During 2005 we presented
our clinical trial data at the American Diabetes Assoc elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ation and the North
American Association for the Study of Obesity annual meetings. Is FBCx the miracle-in-a-bottle that is going to solve the obesity epidemic? Probably not, but used as directed it is a safe and effective means of reducing and maintaining your body weight tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:It's Time To Step Up To The Plate, The World Needs Us, Printing, Promotional Products What's Up! Negotiation-Dealing With Price And The Closing Stages 5 Tips To Know Before Applying For A Loan
|